Skip to main content
. 2017 Dec 20;41(3):1339–1348. doi: 10.3892/ijmm.2017.3334

Figure 5.

Figure 5

Point mutation at Cys183 partially prevents S-nitrosylation of ERK1 in glioma cells. (A) Location of Cys and the adjacent amino acids in the ERK1 protein sequence. The red 'C' in the middle of each box is cysteine residue. (B) Transfection efficiency and S-nitrosylation of ERK1WT and ERK1C183A were determined by biotin switch assay, followed by western blotting. (C) Semi-quantitative analysis of ERK1-SNO levels. β-actin was used as a loading control. *P<0.05 compared with the ERK1WT group. Cys, cystein; ERK, extracellular signal-regulated kinase; SNO, S-nitrosothiol; IB, immunoblotting; WT, wild-type.